Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 3Phase 4 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Endocrine 3

Conditions

Pituitary Neoplasms 2Prolactinoma 1Pituitary ACTH Hypersecretion 1Hyperprolactinemia 1Adenoma 1ACTH-Secreting Pituitary Adenoma 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Cabergoline × Clear all
NCT07463235 2026-03-13

SPARAGMOS

University of Sao Paulo General Hospital

Phase 3 Recruiting
70 enrolled

Hyperprolactinemia, Prolactinoma

NCT02288962 2025-06-08

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

St. Olavs Hospital

Phase 3 Active not recruiting
60 enrolled
Endocrine

Adenoma, Pituitary Neoplasms

NCT03271918 2017-09-07

Cabergoline in Nonfunctioning Pituitary Adenomas

University of Sao Paulo General Hospital

Phase 3 Completed
140 enrolled
Endocrine

Pituitary Neoplasms

NCT00889525 2009-04-29

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Seth Gordhandas Sunderdas Medical College

Phase 3 Completed
Endocrine

Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡